|
| |
Technical Indicators
Simple Moving Average
Exponential Moving Average
Relative Strength Index
William %R
Money Flow Index
Rate of Change
Percentage Price Oscillator
Moving Average Convergence-Divergence
Stochastic Oscillator (Fast)
Stochastic Oscillator (Slow)
  Gemstar Omg run for your life later limit down sohai xcaliberak 1 day show only ... haha hehe 23/07/2020 3:58 PM Gemstar Poor kid xcaliberak like to follow me .. lastime giv u call buy at scomnet at 0.700 highest rm1.6 ...say I hardcore promoter ... u think I so powerful meh stupid...you see yspsah 1 day show nia trap ppl lah you...boh chow c a... retard follow my call if you wanna earn money .. buy cal plabs 0.235 highest 0.32... what u wanna to complain ... go and bang your head and look lah 23/07/2020 4:22 PM Gemstar If scomnet up to rm2 don’t 4 get belanja me ... omg my topglove, harta and Superman... huat ahhhhh 23/07/2020 4:39 PM Gemstar Xcaliberak where are you hiding in sand now izit... omg goodness my topglove rm26.12 ... wow ... tell you don’t always bicker with me ... guys remember donate some of your wealth to unfortunate ppl ... god bless us... 23/07/2020 5:09 PM pingoboy Thank you. I will hold and Q again at lower price to bring down my average cost. @Iamnotasifu Just hold, same tactic from sharks and IBs again, make it limit up then everyone coming to buy, on the second day morning sure a lot of sellings due to profit taking and it form a V shaped recovery in afternoon. Just hold it la, no worries lol 24/07/2020 2:35 PM kd88 A vaccine in development by the British-Swedish company AstraZeneca and the University of Oxford is based on a chimpanzee adenovirus called ChAdOx1. Their Phase I/II trial, reported on July 20 in the journal Lancet, found that the vaccine was safe, causing no severe side effects. It raised antibodies against the coronavirus as well as other immune defenses. The vaccine is now in a Phase II/III trial in England, as well as Phase III trials in Brazil and South Africa. The project may deliver emergency vaccines by October. AstraZeneca has said their total manufacturing capacity for the vaccine, if approved, stands at two billion doses. 25/07/2020 11:49 AM kd88 The German company BioNTech has entered into collaborations with Pfizer, based in New York, and the Chinese drug maker Fosun Pharma to develop their mRNA vaccine. In July, they posted preliminary results from their Phase I/II trials in the United States and Germany. They found that the volunteers produced antibodies against SARS-CoV-2, as well as immune cells called T cells that respond to the virus. Some volunteers experienced moderate side effects such as sleep disturbances and sore arms. The company expects to start Phase III trials by the end of July. On July 22, the Trump administration awarded a $1.9 billion contract for 100 million doses to be delivered by December and the option to acquire 500 million more doses. If approved, Pfizer said they expect to manufacture over 1.3 billion doses of their vaccine by the end of 2021. 25/07/2020 11:50 AM Toplove888 Sleep counter waited for so long finally sold off earn less than my penny... laggard healthcare 27/07/2020 6:38 AM charlietan89 Finally, YSPSAH, warmed Up and ready to go fly like other Pharma stocks! 06/08/2020 1:00 AM pinetree88 Got in today YSP at 2.67. Was looking at duopharma last wk but missed out at 2.7+. But saw YSP valuations seem cheaper than the duo, kontra and the rest. 10/08/2020 4:16 PM Fly888888 pharma , dpharma sudah terbang ... amboi , ysp bila kau terbang ye ... ? 13/08/2020 3:20 PM hahasong 现在很多人买PWORTH股票 很便宜，0.04 值得购买！ Many people now buy PWORTH stock Very cheap, 0.04 worth buying! 18/08/2020 9:39 AM ShareNews wah...this company rich of CASH of 104mils...almost 74sen per share with low borrowings. BUY BUY BUY 26/08/2020 10:18 AM Keyman188 As per 2019 annual report Cash & Cash equivalent : RM 90,083,000 Less Loan & Borrowings : RM 28,831,000 + RM 9,915,000 So net cash now : RM 51,337,000 ** Don't simply tembak 26/08/2020 10:22 AM Klse0314 good counter to invest no matter long term or short term, long term invest to earn dividend compared bank interest which lower now. short term invest if vaccine is available, investor favor hearth care counter 26/08/2020 11:10 AM cpng 永信藥品聚焦重症感染藥物 今年營運續增6% 永信藥品聚焦發展重症感染藥物，深化自原料藥至製劑垂直整合技術能力；今年因應疫情衝擊拉高原料庫存，原料成本均上揚，全年業績仍可望拚6%成長，維持穩定成長趨勢。 永信藥品今年由於疫情關係，各國對於抗疫物資的出口已相對保守，原物料供應鏈不若以往寬鬆，為確保生產線供貨穩定，避免來自中國大陸的料缺貨，去年底已陸續將原料存量拉高35%，目前外銷市場及內銷市場約2比8，每年成長6%的目標不變，各個品項成長動能均衡。 永信為全球少數擁有生物醱酵、化學合成技術以及藥品處方快篩技術綜合型藥廠。 近年來，由於抗生素的廣泛使用而產生抗藥性細菌，對病患健康產生重大威脅。 過去由於注射型抗黴菌藥物藥價昂貴、與臨床使用上的安全性問題，限制了病患的用藥時機與療程。 永信針對感染性疾病，持續深耕發展抗感染藥物，除了早期開發的廣效型抗生素藥物、中期發展預防性黴菌感染與抗病毒藥物，近期更朝向需求日增的重症感染領域，目前已經成功開發3項產品。 其中與台微體攜手合作，掌握特殊奈米化微脂體劑型的關鍵製程，已成功量產Amphotericin B （微脂體製劑），目前正配合進行歐、美、中等大型市場的查登作業。 03/09/2020 10:02 AM cpng Taiwanese new special medicine Silmitasertib (CX-4945) cured covid 19 in 5 days time. http://www.senhwabiosciences.com/tw/new?cls=1491881153&guid=1599104946 03/09/2020 2:15 PM hahasong United States vaccine failed! The glove unit ESCERAM 0100 is about to fly! 17/09/2020 9:34 AM  | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
